lancet-header

Preprints with The Lancet is a collaboration between The Lancet Group of journals and SSRN to facilitate the open sharing of preprints for early engagement, community comment, and collaboration. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early-stage research papers that have not been peer-reviewed. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. The findings should not be used for clinical or public health decision-making or presented without highlighting these facts. For more information, please see the FAQs.

Implications of Cytotoxic and Inflammatory Human IL-7 Receptor Alpha Low Effector Memory CD8+ T Cells in Lupus

34 Pages Posted: 11 Mar 2025

See all articles by Sangjin Lee

Sangjin Lee

Yale University - Department of Internal Medicine

Min Sun Shin

Yale University - Department of Internal Medicine

Yeon-Joo Lee

Cedars-Sinai Medical Center

Lais Osmani

Yale University - Department of Internal Medicine

Won Jae Seong

Yale University - Department of Internal Medicine

Helen Cai

Yale University - Department of Internal Medicine

Jennefer Par-Young

Yale University - Department of Internal Medicine

Jong Gyun Ahn

Yale University - Department of Internal Medicine

Hong-Jai Park

Yale University - Department of Internal Medicine

Minhyung Kim

Cedars-Sinai Medical Center

Serhan Unlu

Yale University - Department of Internal Medicine

Hyoung Su Kim

Hallym University

Man Hoon Han

Kyungpook National University

Xuemei Dong

Yale University - Department of Internal Medicine

Sungyong You

Cedars-Sinai Medical Center

Eun Bong Lee

Seoul National University - Division of Rheumatology

Insoo Kang

Yale University - Department of Internal Medicine

More...

Abstract

Background: This study aims to interrogate the implications of CD8+ T cells in lupus by examining CD8+ T cell heterogeneity and assessing the significance of this heterogeneity in promoting inflammation and tissue damage.

Methods: Our own and publicly available RNA-seq and microarray data from the peripheral blood and kidney tissues of lupus patients were analyzed. Imaging Mass Cytometry (IMC) analysis of immune cells was conducted in lupus and normal kidney tissues. The effects of CD8+ T cell subsets on neutrophils and monocytes were evaluated ex vivo.

Findings: Our scRNA-seq analysis showed an expansion of effector memory (EM) CD8+ T cell subsets that expressed low levels of the IL7 receptor gene (IL7Rlow) but high levels of cytotoxicity genes, including GZMB, GZMK, PRF1, and GNLY, in the peripheral blood and kidneys of lupus patients. CD8+ T cell infiltrations and cytotoxic molecule expression in lupus kidney tissues were associated with treatment outcomes, as determined by IMC. The gene signatures of IL7Rlow CD8+ T cell subsets correlated with type I IFN gene signature in the peripheral blood of pediatric and adult lupus patients. IL7Rlow EM CD8+ T cells induced neutrophil extracellular trap (NET) and augmented lupus immune complex-mediated monocyte activation, key inflammatory pathways in lupus pathogenesis, dependently of TNF-a and IFN-g.

Interpretation: Our study provides unique insights into lupus pathogenesis by demonstrating the clinical and biological implications of cytotoxic and inflammatory IL7Rlow EM CD8+ T cell expansion in lupus. This raises the prospect of therapeutic targets aimed at such CD8+ T cells.

Keywords: CD8+ T cells, Lupus, IL7 receptor, Neutrophils, and Monocytes

Suggested Citation

Lee, Sangjin and Shin, Min Sun and Lee, Yeon-Joo and Osmani, Lais and Seong, Won Jae and Cai, Helen and Par-Young, Jennefer and Ahn, Jong Gyun and Park, Hong-Jai and Kim, Minhyung and Unlu, Serhan and Kim, Hyoung Su and Han, Man Hoon and Dong, Xuemei and You, Sungyong and Bong Lee, Eun and Kang, Insoo, Implications of Cytotoxic and Inflammatory Human IL-7 Receptor Alpha Low Effector Memory CD8+ T Cells in Lupus. Available at SSRN: https://ssrn.com/abstract=5172473 or http://dx.doi.org/10.2139/ssrn.5172473

Sangjin Lee

Yale University - Department of Internal Medicine ( email )

Min Sun Shin

Yale University - Department of Internal Medicine ( email )

Yeon-Joo Lee

Cedars-Sinai Medical Center ( email )

8700 Beverly Blvd
Los Angeles, CA 90048
United States

Lais Osmani

Yale University - Department of Internal Medicine ( email )

Won Jae Seong

Yale University - Department of Internal Medicine ( email )

Helen Cai

Yale University - Department of Internal Medicine ( email )

Jennefer Par-Young

Yale University - Department of Internal Medicine ( email )

Jong Gyun Ahn

Yale University - Department of Internal Medicine ( email )

Hong-Jai Park

Yale University - Department of Internal Medicine ( email )

Minhyung Kim

Cedars-Sinai Medical Center ( email )

8700 Beverly Blvd
Los Angeles, CA 90048
United States

Serhan Unlu

Yale University - Department of Internal Medicine ( email )

Hyoung Su Kim

Hallym University ( email )

39 Hallymdaehak-gil
Chuncheon, Gangwon-do, 200-702
Korea, Republic of (South Korea)

Man Hoon Han

Kyungpook National University ( email )

Xuemei Dong

Yale University - Department of Internal Medicine ( email )

Sungyong You

Cedars-Sinai Medical Center ( email )

8700 Beverly Blvd
Los Angeles, CA 90048
United States

Eun Bong Lee

Seoul National University - Division of Rheumatology ( email )

Insoo Kang (Contact Author)

Yale University - Department of Internal Medicine ( email )